Stockscreener 앱 받기
33.64
2.44%
0.80
시간 외 거래:
30.08
-3.56
-10.58%
전일 마감가:
$32.84
열려 있는:
$33.47
하루 거래량:
1.81M
Relative Volume:
1.34
시가총액:
$2.90B
수익:
$191.42M
순이익/손실:
$-111.83M
주가수익비율:
-25.38
EPS:
-1.3253
순현금흐름:
$-76.77M
1주 성능:
+9.68%
1개월 성능:
+31.18%
6개월 성능:
+17.42%
1년 성능:
+0.00%
1일 변동 폭
$32.69
$33.92
1주일 범위
$30.00
$34.31
52주 변동 폭
$20.13
$41.22
Heartflow Inc Stock (HTFL) Company Profile
명칭
Heartflow Inc
전화
650-241-1221
주소
135 MAIN STREET, SUITE 1000, SAN FRANCISCO
Compare HTFL vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HTFL
Heartflow Inc
|
33.64 | 2.90B | 191.42M | -111.83M | -76.77M | -1.3253 |
VEEV
Veeva Systems Inc
|
153.30 | 24.90B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
66.25 | 13.00B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.84 | 9.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.21 | 7.12B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
69.42 | 5.37B | 646.34M | -512.40M | 202.76M | -6.6871 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-28 | 개시 | Wells Fargo | Overweight |
| 2025-09-02 | 개시 | Canaccord Genuity | Buy |
| 2025-09-02 | 개시 | JP Morgan | Overweight |
| 2025-09-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-02 | 개시 | Piper Sandler | Overweight |
| 2025-09-02 | 개시 | Stifel | Buy |
모두보기
Heartflow Inc 주식(HTFL)의 최신 뉴스
Heartflow (HTFL) director Weldon awarded 16,075 stock options at $32.05 strike - Stock Titan
Heartflow (HTFL) director receives 16,075 stock options at $32.05 strike - Stock Titan
Heartflow (HTFL) awards director Julie Cullivan 16,075 stock options - Stock Titan
Heartflow (HTFL) director granted 16,075 stock options at $32.05 - Stock Titan
Heartflow (HTFL) director granted 16,075 stock options at $32.05 exercise price - Stock Titan
[Form 4] Heartflow, Inc. Insider Trading Activity - Stock Titan
Heartflow (NASDAQ: HTFL) holders back board picks, approve auditor - Stock Titan
Heartflow Inc (HTFL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Heartflow Inc (HTFL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Heartflow Inc (HTFL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Heartflow Inc (HTFL) Institutional Confidence - TradingKey
Heartflow Inc (HTFL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Heartflow Inc (HTFL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Heartflow Inc (HTFL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Heartflow (HTFL) CMO exercises 10,000 options under 10b5-1 plan - Stock Titan
Heartflow Inc (HTFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap - Benzinga
Lobbying Update: $90,000 of HEARTFLOW INC. lobbying was just disclosed - Quiver Quantitative
Piper Sandler Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $38 - Moomoo
HeartFlow Inc (HTFL) CEO John Farquhar Sells 22,562 Shares - GuruFocus
Heartflow CEO John Farquhar sells $643,017 in company stock - Investing.com UK
Heartflow CEO John Farquhar sells $643,017 in company stock By Investing.com - Investing.com Australia
Heartflow (HTFL) CEO Farquhar sells 22,562 shares under Rule 10b5-1 plan - Stock Titan
HeartFlow Stock Jumps as Wall Street Stays Bullish - TipRanks
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE) - The Globe and Mail
Piper Sandler reiterates Heartflow stock rating on plaque revenue - Investing.com UK
Piper Sandler reiterates Heartflow stock rating on plaque revenue By Investing.com - Investing.com Australia
Why HeartFlow, Inc. Shares Are Surging Today - TipRanks
[144] Heartflow, Inc. SEC Filing - Stock Titan
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? - AOL.com
Patent Infringement Lawsuit Alleges "Piracy" of AI-Driven Medical Technology - The National Law Review
A Look At HeartFlow (HTFL) Valuation As Analyst Fair Value Diverges From Current Share Price - Yahoo Finance
Stifel reiterates Heartflow stock rating on clinical data strength - Investing.com
Carlyle Group Inc.'s HeartFlow Inc(HTFL) Holding History - GuruFocus
TFC Financial Management, Inc.'s HeartFlow Inc(HTFL) Holding History - GuruFocus
HTFL Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 8.4% on Broader OptimismEarnings Outlook Update - newsline.com
Heartflow Inc. (HTFL) Surges 3.1% as Bulls Test Key Resistance at $30.74PCR Mean Reversion - newsline.com
Heartflow Inc. (HTFL) Q1 2026 Earnings: EPS Misses Estimates Amid Key Operational DevelopmentsBook Value Growth - newsline.com
HeartFlow Q1 earnings call highlights - MSN
12 West Capital Management LP's HeartFlow Inc(HTFL) Holding History - GuruFocus
A Quick Look at Today's Ratings for Heartflow(HTFL.US), With a Forecast Between $35 to $37 - Moomoo
Heartflow CMO Campbell Rogers sells $261,266 of common stock By Investing.com - Investing.com South Africa
Heartflow CMO Campbell Rogers sells $261,266 of common stock - Investing.com
Heartflow (HTFL) CMO sells 9,219 shares after option exercise under 10b5-1 plan - Stock Titan
Earnings call transcript: HeartFlow Q1 2026 beats EPS expectations, stock falls - Investing.com
Why HeartFlow’s Stock Is Suddenly Sinking Hard - TipRanks
HTFL (NASDAQ: HTFL) Form 144 lists 86,240,828-share resale; recent trades noted - Stock Titan
Heartflow (HTFL) Stock Today: Drops -9.43%, Key Support at $24.36 2026-05-18Diamond Pattern - newsline.com
Why HeartFlow Stock Is Racing Higher Today - TipRanks
Companies Like HeartFlow (NASDAQ:HTFL) Are In A Position To Invest In Growth - Sahm
HTFL Maintained by Canaccord Genuity -- Price Target Lowered to $37 - GuruFocus
Heartflow Inc (HTFL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
자본화:
|
볼륨(24시간):